Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4129)
All Articles published online
|
Jun 14, 2006 (publication date) through Apr 18, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pusl T, Beuers U. Ursodeoxycholic acid treatment of vanishing bile duct syndromes. World J Gastroenterol 2006; 12(22): 3487-3495 [PMID: 16773706 DOI: 10.3748/wjg.v12.i22.3487] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i22/3487.htm |
| Number | Citing Articles |
| 1 |
T.G. Berezna, O.B. Synoverska, N.M. Fomenko. Biliary sludge syndrome induced by cephalosporins in children: clinical and diagnostic markers, management. CHILD`S HEALTH 2023; 18(6): 453 doi: 10.22141/2224-0551.18.6.2023.1633
|
| 2 |
Andreas E. Kremer, Jamison Feramisco, Peter W. Reeh, Ulrich Beuers, Ronald P.J. Oude Elferink. Receptors, cells and circuits involved in pruritus of systemic disorders. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014; 1842(7): 869 doi: 10.1016/j.bbadis.2014.02.007
|
| 3 |
Michael Chang, Muhammad Baraa Hammami, Sasan Sakiani. A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance. Gastroenterology 2024; 167(6): 1091 doi: 10.1053/j.gastro.2024.05.003
|
| 4 |
Sugunah Sallapan, Kyrillos Faragalla, Hanlin L. Wang, Cherry Pun, Jimin Liu. Vanishing bile duct syndrome in drug-induced liver injury: clinical and pathologic perspectives. Exploration of Medicine 2025; doi: 10.37349/emed.2025.1001302
|
| 5 |
Swetha Palla Velangini, Deepthi Boddu, Shailaja Balakumar, Arul Premanand, Ravi Kishore, Leni G. Mathew. Vanishing Bile Duct Syndrome Secondary to Hodgkin Lymphoma in a Child. Journal of Pediatric Hematology/Oncology 2022; 44(6): e945 doi: 10.1097/MPH.0000000000002505
|
| 6 |
Yuebo Jia, Lin Liu, Baocheng Deng, Yu Huang, Jiaqi Zhao, Guang Bai. Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report. Diagnostic Pathology 2022; 17(1) doi: 10.1186/s13000-022-01228-1
|
| 7 |
Satoko Yui, Ryuhei Kanamoto, Tohru Saeki. Deoxycholic Acid Can Induce Apoptosis in the Human Colon Cancer Cell Line HCT116 in the Absence of Bax. Nutrition and Cancer 2007; 60(1): 91 doi: 10.1080/01635580701525893
|
| 8 |
David Q-H Wang, Martin C Carey. Therapeutic uses of animal biles in traditional Chinese medicine: An ethnopharmacological, biophysical chemical and medicinal review. World Journal of Gastroenterology 2014; 20(29): 9952-9975 doi: 10.3748/wjg.v20.i29.9952
|
| 9 |
Jonathan G. Stine, Naga Chalasani. Chronic liver injury induced by drugs: a systematic review. Liver International 2015; 35(11): 2343 doi: 10.1111/liv.12958
|
| 10 |
Kazuto Tajiri, Yukihiro Shimizu. Recent advances in the management of pruritus in chronic liver diseases. World Journal of Gastroenterology 2017; 23(19): 3418-3426 doi: 10.3748/wjg.v23.i19.3418
|
| 11 |
Delia Rota Scalabrini, Daniela Caravelli, Fabrizio Carnevale Schianca, Lorenzo D’Ambrosio, Francesco Tolomeo, Paola Boccone, Antonio Manca, Giovanni De Rosa, Annamaria Nuzzo, Massimo Aglietta, Giovanni Grignani. Complete remission of paraneoplastic vanishing bile duct syndrome after the successful treatment of Hodgkin’s lymphoma: a case report and review of the literature. BMC Research Notes 2014; 7(1) doi: 10.1186/1756-0500-7-529
|
| 12 |
Yukihisa Fujinaga, Tadashi Namisaki, Kei Moriya, Mitsuteru Kitade, Hideto Kawaratani, Naotaka Shimozato, Kosuke Kaji, Hiroaki Takaya, Yasuhiko Sawada, Kenichiro Seki, Takemi Akahane, Yasushi Okura, Shinya Sato, Soichiro Saikawa, Keisuke Nakanishi, Takuya Kubo, Masanori Furukawa, Koh Kitagawa, Takahiro Ozutsumi, Yuki Tsuji, Daisuke Kaya, Tsuyoshi Mashitani, Koji Ishida, Hiroyuki Ogawa, Hirotetsu Takagi, Ryuichi Noguchi, Akira Mitoro, Junichi Yamao, Hitoshi Yoshiji. Identification of clinical risk factors for histological progression of primary biliary cholangitis. Hepatology Research 2019; 49(9): 1015 doi: 10.1111/hepr.13355
|
| 13 |
Sharon A. Center. Diseases of the Gallbladder and Biliary Tree. Veterinary Clinics of North America: Small Animal Practice 2009; 39(3): 543 doi: 10.1016/j.cvsm.2009.01.004
|
| 14 |
Hyun Jeong Cho, Hye Jeong Jwa, Kyu Seon Kim, Dae Yong Gang, Jae Young Kim. Urosodeoxycholic Acid Therapy in a Child with Trimethoprim-Sulfamethoxazole-induced Vanishing Bile Duct Syndrome. Pediatric Gastroenterology, Hepatology & Nutrition 2013; 16(4): 273 doi: 10.5223/pghn.2013.16.4.273
|
| 15 |
Judah D Morgan, Robert C Weishar, Ryan M Kwok, Kenneth M Lieuw. Hodgkin lymphoma associated vanishing bile duct syndrome treated successfully with a brentuximab based regimen. BMJ Case Reports 2023; 16(11): e257211 doi: 10.1136/bcr-2023-257211
|
| 16 |
Magdalena Kusaczuk. Tauroursodeoxycholate—Bile Acid with Chaperoning Activity: Molecular and Cellular Effects and Therapeutic Perspectives. Cells 2019; 8(12): 1471 doi: 10.3390/cells8121471
|
| 17 |
Mansoor Zafar, Mariya Farooq, William Butler- Manuel, Mohammad Fawad Khattak, Usman Iqbal Rana, Tila Muhammad, Ian Hawley, Mark Whitehead, Muhammad Toqeer. Vanishing Bile Duct Syndrome Associated With Non-Hodgkin’s Lymphoma and Hepatitis E Virus Infection. Cureus 2022; doi: 10.7759/cureus.21328
|
| 18 |
Adam Mazzetti, Resheed Alkhiari, Vidhya Nair, Ted Xenodemetropoulos. Hepatic Ductopenia and Vanishing Bile Duct Syndrome following Anabolic Androgenic Steroid Use: A Case Report and Literature Review. Canadian Journal of General Internal Medicine 2017; 12(4): 32 doi: 10.22374/cjgim.v12i4.156
|
| 19 |
Hui Wang, Gil Yosipovitch. New insights into the pathophysiology and treatment of chronic itch in patients with end‐stage renal disease, chronic liver disease, and lymphoma. International Journal of Dermatology 2010; 49(1): 1 doi: 10.1111/j.1365-4632.2009.04249.x
|
| 20 |
Kosuke Sumida, Kazufumi Dohmen, Shinichi Aishima, Sho Iwasaka, Satomi Hisamoto, Yukiko Harada, Noriko Miyake, Nobuyuki Shimono, Shinji Shimoda. A case of vanishing bile duct syndrome complicated with toxic epidermal necrolysis performed liver biopsy three times subsequently. Kanzo 2013; 54(1): 67 doi: 10.2957/kanzo.54.67
|
| 21 |
Andreas E Kremer, Ulrich Beuers, Ronald P J Oude-Elferink, Thomas Pusl. Pathogenesis and Treatment of Pruritus in Cholestasis. Drugs 2008; 68(15): 2163 doi: 10.2165/00003495-200868150-00006
|
| 22 |
Matthew Mason, Oyedele Adeyi, Scott Fung, Barbara-Ann Millar. Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma. BMJ Case Reports 2014; : bcr2014208117 doi: 10.1136/bcr-2014-208117
|
| 23 |
Jingli Cai, Zhaowen Wang, Guiming Chen, Dapeng Li, Jun Liu, Hai Hu, Jian Qin. Reabsorption of bile acids regulated by FXR-OATP1A2 is the main factor for the formation of cholesterol gallstone. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 319(3): G303 doi: 10.1152/ajpgi.00385.2019
|
| 24 |
Carlos M. Rodríguez‐Ortigosa, Jesús M. Banales, Israel Olivas, Iker Uriarte, José J.G. Marín, Fernando J. Corrales, Juan F. Medina, Jesús Prieto. Biliary secretion of S‐nitrosoglutathione is involved in the hypercholeresis induced by ursodeoxycholic acid in the normal rat†. Hepatology 2010; 52(2): 667 doi: 10.1002/hep.23709
|
| 25 |
Gideon M. Hirschfield, Teru Kumagi, E. Jenny Heathcote. Preventative hepatology: minimising symptoms and optimising care. Liver International 2008; 28(7): 922 doi: 10.1111/j.1478-3231.2008.01816.x
|
| 26 |
Nancy S. Reau, Donald M. Jensen. Vanishing Bile Duct Syndrome. Clinics in Liver Disease 2008; 12(1): 203 doi: 10.1016/j.cld.2007.11.007
|
| 27 |
Piero Boraschi, Francescamaria Donati. Postoperative biliary adverse events following orthotopic liver transplantation: Assessment with magnetic resonance cholangiography. World Journal of Gastroenterology 2014; 20(32): 11080-11094 doi: 10.3748/wjg.v20.i32.11080
|
| 28 |
Rachita Khot, Nathan R. Shelman, Daniel R. Ludwig, Rashmi T. Nair, Mark A. Anderson, Sudhakar K. Venkatesh, Raj Mohan Paspulati, Rex A. Parker, Christine O. Menias. Acquired ductopenia: an insight into imaging findings. Abdominal Radiology 2024; 50(1): 152 doi: 10.1007/s00261-024-04462-x
|
| 29 |
Paolo Izzo, Gaetano Gallo, Massimo Codacci Pisanelli, Giuliano D’Onghia, Leonardo Macci, Raimondo Gabriele, Andrea Polistena, Luciano Izzo, Sara Izzo, Luigi Basso. Vanishing Bile Duct Syndrome in an Adult Patient: Case Report and Review of the Literature. Journal of Clinical Medicine 2022; 11(12): 3253 doi: 10.3390/jcm11123253
|
| 30 |
Maria J Perez, Oscar Briz. Bile-acid-induced cell injury and protection. World Journal of Gastroenterology 2009; 15(14): 1677-1689 doi: 10.3748/wjg.15.1677
|
| 31 |
M. S. Rocha, F. A. Herbella, J. C. Del Grande, A. T. Ferreira, C. Tahan, M. G. Patti. Effects of ursodeoxycholic acid in esophageal motility and the role of the mucosa. An experimental study. Diseases of the Esophagus 2011; 24(4): 291 doi: 10.1111/j.1442-2050.2010.01137.x
|
| 32 |
M. Beaussier, E. Schiffer, C. Housset. La cholestase ischémique en réanimation. Annales Françaises d'Anesthésie et de Réanimation 2008; 27(9): 709 doi: 10.1016/j.annfar.2008.04.019
|
| 33 |
Hui Yang, Hang Yang, Lixia Wang, Honggang Shi, Bojia Liu, Xue Lin, Qingyong Chang, Jiande D. Z. Chen, Zhijun Duan. Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study. BMC Complementary Medicine and Therapies 2020; 20(1) doi: 10.1186/s12906-020-03036-w
|
| 34 |
Andreas E. Kremer, Ronald P.J. Oude Elferink, Ulrich Beuers. Pathophysiology and current management of pruritus in liver disease. Clinics and Research in Hepatology and Gastroenterology 2011; 35(2): 89 doi: 10.1016/j.clinre.2010.10.007
|
| 35 |
Javier Martínez, Lara Aguilera, Agustín Albillos. Risk stratification and treatment of primary biliary cholangitis. Revista Española de Enfermedades Digestivas 2018; 111 doi: 10.17235/reed.2018.5662/2018
|
| 36 |
Ali Shorbagi, Yusuf Bayraktar. Primary sclerosing cholangitis - What is the difference between east and west?. World Journal of Gastroenterology 2008; 14(25): 3974-3981 doi: 10.3748/wjg.14.3974
|
| 37 |
Kai Rou Tey, Kristen Barrett, Richa Jain, Thomas D. Boyer, Archita Desai. Vanishing Bile Duct Syndrome with Hemophagocytic Lymphohistiocytosis After Minimal Change Disease. The American Journal of Medicine 2016; 129(12): e315 doi: 10.1016/j.amjmed.2016.05.029
|
| 38 |
Yuchen Li, Lori Stewart, Shangguo Tang, Elaine McWhirter. Pembrolizumab-induced immune-related sclerosing cholangitis. BMJ Case Reports 2023; 16(11): e256125 doi: 10.1136/bcr-2023-256125
|
| 39 |
Qian Zhang, Zhiqiang Liu, Shanshan Wu, Weijia Duan, Sha Chen, Xiaojuan Ou, Hong You, Yuanyuan Kong, Jidong Jia. Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis. Gastroenterology Research and Practice 2019; 2019: 1 doi: 10.1155/2019/8959103
|
| 40 |
Rachel Shireen Golpanian, Gil Yosipovitch, Roni P. Dodiuk-Gad. Drug Eruptions. Updates in Clinical Dermatology 2022; : 211 doi: 10.1007/978-3-031-09388-3_18
|
| 41 |
Songül Budak DİLER, Fikriye POLAT, Eyüp ÖZER. Ursodeoksikolik Asit’in İnsan Periferal Kan Lenfositlerindeki in Vitro Genotoksik Etkisi. Iğdır Üniversitesi Fen Bilimleri Enstitüsü Dergisi 2018; 8(1): 69 doi: 10.21597/jist.407835
|
| 42 |
Kamyar Nader, Shaffer Mok, Ankur Kalra, Antoine Harb, Roland Schwarting, Andres Ferber. Vanishing Bile Duct Syndrome as a Manifestation of Hodgkin's Lymphoma: A Case Report and Review of the Literature. Tumori Journal 2013; 99(4): e164 doi: 10.1177/030089161309900426
|
| 43 |
Luka Suzuki, Satoshi Hirayama, Mariko Fukui, Makoto Sasaki, Sadayuki Hiroi, Makoto Ayaori, Shuji Terai, Minoru Tozuka, Hirotaka Watada, Takashi Miida. Lipoprotein-X in cholestatic patients causes xanthomas and promotes foam cell formation in human macrophages. Journal of Clinical Lipidology 2017; 11(1): 110 doi: 10.1016/j.jacl.2016.10.013
|
| 44 |
Haein Bak, Hayeon Kim, Sieun Lee, Yoonseok Lee, Soo-Min Bang, Young-Sun Lee. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen. Yonsei Medical Journal 2020; 61(12): 1060 doi: 10.3349/ymj.2020.61.12.1060
|
| 45 |
C.M. Hall, S. Glaser, G. Alpini. Comprehensive Toxicology. 2018; : 41 doi: 10.1016/B978-0-12-801238-3.95660-5
|
| 46 |
|
| 47 |
Weronika Kozanecka-Okupnik, Beata Jasiewicz, Tomasz Pospieszny, Monika Matuszak, Lucyna Mrówczyńska. Haemolytic activity of formyl- and acetyl-derivatives of bile acids and their gramine salts. Steroids 2017; 126: 50 doi: 10.1016/j.steroids.2017.07.003
|
| 48 |
Dirk R. de Waart, Ronald P. J. Oude Elferink. Transporters as Drug Carriers. Methods and Principles in Medicinal Chemistry 2009; 44: 299 doi: 10.1002/9783527627424.ch11
|
| 49 |
Masashi Miyao, Munetaka Ozeki, Hitoshi Abiru, Sho Manabe, Hirokazu Kotani, Tatsuaki Tsuruyama, Keiji Tamaki. Bile canalicular abnormalities in the early phase of a mouse model of sclerosing cholangitis. Digestive and Liver Disease 2013; 45(3): 216 doi: 10.1016/j.dld.2012.09.007
|
| 50 |
P. Yeh, J. Lokan, A. Anantharajah, A. Grigg. Vanishing bile duct syndrome and immunodeficiency preceding the diagnosis of Hodgkin lymphoma. Internal Medicine Journal 2014; 44(12a): 1240 doi: 10.1111/imj.12609
|
| 51 |
Stephanie W. Liu, Mary H. Lien, Neil Alan Fenske. The effects of alcohol and drug abuse on the skin. Clinics in Dermatology 2010; 28(4): 391 doi: 10.1016/j.clindermatol.2010.03.024
|
| 52 |
Jocelyn Trottier, Andrzej Białek, Patrick Caron, Robert J. Straka, Jenny Heathcote, Piotr Milkiewicz, Olivier Barbier. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study. Digestive and Liver Disease 2012; 44(4): 303 doi: 10.1016/j.dld.2011.10.025
|
| 53 |
Sha Li, Hor Yue Tan, Ning Wang, Ming Hong, Lei Li, Fan Cheung, Yibin Feng, Siyaram Pandey. Substitutes for Bear Bile for the Treatment of Liver Diseases: Research Progress and Future Perspective. Evidence-Based Complementary and Alternative Medicine 2016; 2016(1) doi: 10.1155/2016/4305074
|
| 54 |
|
| 55 |
Ju-Hwan Park, Min-Jun Baek, Jae-Young Lee, Ki-Taek Kim, Hyun-Jong Cho, Dae-Duk Kim. Preparation and characterization of sorafenib-loaded microprecipitated bulk powder for enhancing oral bioavailability. International Journal of Pharmaceutics 2020; 589: 119836 doi: 10.1016/j.ijpharm.2020.119836
|
| 56 |
Hongwei He, Albert Mennone, James L. Boyer, Shi-Ying Cai. Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells. Hepatology 2011; 53(2): 548 doi: 10.1002/hep.24047
|
| 57 |
Micha Loebermann, Martina Sombetzki, Cord Langner, Andrea Fuchsbichler, Judith Gumhold, Dagmar Silbert, Diana Riebold, Martha Holtfreter, Peter Fickert, Horst Nizze, Michael Trauner, Emil C. Reisinger. Imbalance of pro‐ and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection–induced liver fibrosis. Tropical Medicine & International Health 2009; 14(11): 1418 doi: 10.1111/j.1365-3156.2009.02387.x
|